Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

10h Pictures: Kelly Piquet shares clicks featuring Max Verstappen, Penelope Kvyat, and Lily Verstappen from the New Year's Eve get-together Pictures: Kelly Piquet shares clicks featuring Max ...